ArticleInternational journal of clinical oncology2025

Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer.

Tokiyoshi Tanegashima et al.PubMed ↗Publisher ↗

No numbers read from the abstract.